NanoDev Therapeutics

Categories: Health, Innovators

NanoDev Therapeutics was founded in April 2016 by a dedicated five member team of researchers from the Mayo Clinic and biotech professionals from MNPHARM to form a strategic partnership to advance and develop nanobody technology for the treatment of disease with a focus on cancer. Nanobodies are single cell domain antibodies, the next frontier in the field of medical therapeutic discovery.

Nanodev Therapeutics will utilize three techniques to express recombinant nanobody proteins to expand and expedite discovery. Mayo Clinic researchers will provide expertise in E.coli and mammalian expressions methods while MNPHARM will provide expertise in plant based expression methods.

View Resource